A Microfluidic Device Squeezes Cells to Deliver Drugs
- Though the technology is only a research tool now, it might be just what’s needed to bring some promising new cancer and HIV therapies to patients.
- SQZ says it may be able to significantly cut the costs of immunotherapy and improve its effectiveness, factors that have prevented it from being commercialized
- SQZ’s devices are currently being used by a number of biologists, and the company is in the early stages of testing it for use with experimental treatments.
As a Futurism reader, we invite you join the Singularity Global Community, our parent company’s forum to discuss futuristic science & technology with like-minded people from all over the world. It’s free to join, sign up now!